Jinhai International Group Holdings Limited (2225) AI Stock Analysis

• Market Cap: HK$8.53B
• Dividend Yield: N/A
• Average Volume (3M): 3.50M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.01
• Revenue Growth: 10.56%
• EPS Growth: -466.67%
• Country: HK
• Employees: 488
• Sector: Industrials
• Sector Strength: 90
• Industry: Staffing & Employment Services
• EPS (TTM): -0.02
• Shares Outstanding: 5,170,000,000
• 10 Day Avg. Volume: 4,120,575
• 30 Day Avg. Volume: 3,500,191
• PEG Ratio: -3.71
• Price to Book (P/B): 42.86
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 2.29K
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: HK$2.00 ▲(21.21%Upside)

The overall stock score reflects considerable financial weaknesses and unattractive valuation. Despite some technical momentum, the risks associated with poor profitability and cash flow management weigh heavily, making this stock less appealing.

Jinhai International Group Holdings Limited Business Overview & Revenue Model

Company Description

Jinhai International Group Holdings Limited, an investment holding company, primarily provides manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services; information technology services; and construction ancillary services comprising warehousing, cleaning, and building maintenance works. The company was formerly known as Kakiko Group Limited and changed its name to Jinhai International Group Holdings Limited in October 2019. Jinhai International Group Holdings Limited was incorporated in 2017 and is headquartered in Sheung Wan, Hong Kong. Jinhai International Group Holdings Limited is a subsidiary of Full Fortune International Co., Ltd.

How the Company Makes Money

Jinhai International Group Holdings Limited generates revenue through its construction and engineering services, which form the backbone of its business model. The company earns money by undertaking construction projects for both private and public sector clients. Key revenue streams include contract fees for construction projects, project management fees, and consultancy services. The company also benefits financially from strategic partnerships with suppliers and subcontractors, which may provide cost efficiencies and enhanced capabilities in delivering large-scale projects. Additionally, Jinhai International Group Holdings Limited may engage in long-term maintenance contracts, providing steady income streams post-project completion.

Jinhai International Group Holdings Limited Financial Statement Overview

Summary

Jinhai International Group Holdings Limited shows financial challenges with declining revenues, persistent losses, and poor cash flow management. The balance sheet reflects moderate health with manageable leverage, but declining equity and cash flow issues pose significant risks.

Income Statement

The income statement shows a concerning trend with declining revenues from 2019 to 2024 and a negative net income in recent years. Gross profit margins have also decreased, indicating rising costs or pricing pressures. The company has consistently operated at a loss, with negative EBIT and EBITDA margins, raising concerns about operational efficiency and profitability.

Balance Sheet

The balance sheet reflects moderate financial health with a Debt-to-Equity ratio of 0.46 in 2024, suggesting manageable leverage. However, the declining stockholders' equity over time is a warning sign. The equity ratio is stable, indicating that the company relies less on debt financing, but the reduced cash reserves may limit future flexibility.

Cash Flow

The cash flow statement is weak, with zero free cash flow in 2024, indicating poor cash generation from core operations. Historical volatility in operating cash flow and negative free cash flow in some years suggest inconsistent cash management, which could stress liquidity in challenging times.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	50.24M	45.64M	22.28M	21.90M	22.47M
Gross Profit	11.48M	12.03M	10.12M	7.73M	8.85M
EBITDA	-16.82M	1.11M	3.57M	5.44M	2.15M
Net Income	-17.96M	-3.14M	468.00K	-246.21K	1.26M
Balance Sheet
Total Assets	58.87M	62.22M	40.27M	33.77M	39.41M
Cash, Cash Equivalents and Short-Term Investments	14.93M	26.76M	26.05M	25.91M	25.95M
Total Debt	14.52M	10.08M	4.45M	1.87M	5.50M
Total Liabilities	26.09M	24.73M	15.68M	9.75M	13.92M
Stockholders Equity	31.81M	37.47M	24.37M	24.28M	25.49M
Cash Flow
Free Cash Flow	-4.26M	-3.15M	3.06M	2.73M	7.25M
Operating Cash Flow	-3.25M	-1.91M	4.24M	3.34M	7.38M
Investing Cash Flow	-9.22M	-6.51M	-1.15M	-2.64M	-6.04M
Financing Cash Flow	2.93M	13.62M	-3.72M	-4.81M	-4.15M

Jinhai International Group Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.65
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2225, the sentiment is Positive. The current price of 1.65 is above the 20-day moving average (MA) of 1.51, above the 50-day MA of 1.40, and above the 200-day MA of 1.52, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 87.10 is Negative, neither overbought nor oversold. The STOCH value of 83.53 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2225.

Jinhai International Group Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6100	76 Outperform	HK$2.13B	13.41	4.48%	―	-10.48%	30250.00%
Sector *	71 Outperform	¥254.15B	13.65	8.48%	3.02%	6.34%	13.16%
2180	70 Neutral	HK$1.03B	7.32	10.74%	6.26%	16.07%	0.77%
8031	63 Neutral	HK$56.17M	―	-13.66%	―	―	―
8462	62 Neutral	HK$81.00M	4.53	15.12%	―	-17.45%	77.78%
6919	48 Neutral	HK$610.64M	10.94	-5.73%	2.26%	20.23%	-275.42%
2225	44 Neutral	HK$8.53B	―	-52.16%	―	10.56%	-466.67%

Jinhai International Group Holdings Limited Corporate Events

Jinhai Medical Technology Secures New Capital Through Share Subscription

Jinhai Medical Technology Limited announced the signing of three Subscription Agreements with independent private investors to issue a total of 120,000,000 new shares at a price of HK$1.35 per share. This move, under the General Mandate, represents a strategic effort to raise capital without requiring shareholder approval, potentially impacting the company’s market positioning by increasing its share capital by approximately 2.27%. The subscription price reflects a discount to recent market prices, indicating a strategic decision to attract investment under current market conditions.

Jinhai Medical Technology Enhances Risk Management and Updates Share Option Scheme

Jinhai Medical Technology Limited has announced supplementary information to its 2024 Annual Report, focusing on remedial measures for risk management and internal control systems. The company has implemented enhanced internal control policies, conducted training sessions, hired qualified staff, and sought external advice to ensure compliance with the Listing Rules. Additionally, the company provided updates on its Share Option Scheme, detailing the number of options available at the beginning and end of the financial year.

Jinhai Medical Technology Enters Strategic Partnership for Global Endoscope Market Expansion

Jinhai Medical Technology Limited has entered into a five-year cooperation framework agreement with Ningbo Verykind Medical Device Co., Ltd., a subsidiary of David Medical Group, to collaborate on endoscope products for international markets. This partnership aims to enhance product delivery efficiency, cost competitiveness, and global academic influence through resource optimization and international certifications. The agreement is expected to broaden Jinhai’s income stream and align with its development strategy, ultimately benefiting shareholders.

Jinhai Medical Technology Secures Unanimous Shareholder Approval at AGM

Jinhai Medical Technology Limited announced that all resolutions proposed at its Annual General Meeting (AGM) held on June 25, 2025, were unanimously approved by shareholders. The resolutions included the adoption of financial statements, re-election of directors, authorization of director remuneration, re-appointment of auditors, and granting of mandates for share issuance and repurchase. This unanimous approval reflects strong shareholder confidence in the company’s governance and strategic direction, potentially reinforcing its market position and operational stability.

Jinhai Medical Technology Announces 2025 Annual General Meeting

Jinhai Medical Technology Limited has announced its upcoming annual general meeting scheduled for June 25, 2025, in Shanghai, China. Key agenda items include the adoption of the company’s audited financial statements for 2024, the re-election of several directors, and the re-appointment of ZHONGHUI ANDA CPA Limited as the company’s auditor. Additionally, the meeting will address resolutions related to the issuance of shares, which could impact the company’s capital structure and shareholder value.